Myelinating Schwann Cells
Introduction
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Myelinating Schwann Cells</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000218](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000218)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000218](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000218)</td>
</tr>
</table>
Myelinating Schwann Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
...Myelinating Schwann Cells
Introduction
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Myelinating Schwann Cells</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000218](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000218)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000218](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000218)</td>
</tr>
</table>
Myelinating Schwann Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
Myelinating Schwann cells (SCs) are the glial cells responsible for forming the myelin sheath around peripheral nervous system (PNS) axons. Each myelinating SC ensheaths a single axon segment, wrapping its membrane repeatedly to form the multilamellar myelin sheath that enables rapid saltatory conduction ([Nave & Werner, 2014](https://doi.org/10.1016/j.neuroscience.2014.03.032); [Salzer, 2015](https://doi.org/10.1016/j.neuron.2015.09.008)). In neurodegenerative diseases affecting the PNS, including Charcot-Marie-Tooth disease (CMT), Guillain-Barré syndrome (GBS), and diabetic neuropathy, myelinating SCs are primary targets of pathology. Additionally, SC dysfunction contributes to central nervous system (CNS) regeneration failure, as SCs produce growth-promoting molecules that are absent in the adult CNS.
<!-- taxonomy-enrichment -->
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
PanglaoDB Marker Cross-References
External Database Links
- [Cell Ontology (CL:0000218)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000218)
- [OBO Foundry (CL:0000218)](http://purl.obolibrary.org/obo/CL_0000218)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
- [PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links
- [Cell Ontology (CL:0000218)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000218)
- [OBO Foundry (CL:0000218)](http://purl.obolibrary.org/obo/CL_0000218)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [PanglaoDB](https://panglaodb.se/)
Development and Myelination
Neural Crest Origin
Schwann cells derive from neural crest progenitors that migrate along developing peripheral axons. During development, SC precursors differentiate into:
- Immature SCs: Proliferative cells that initially ensheath multiple axons
- Pro-myelinating SCs: Select single large-diameter axons for myelination
- Myelinating SCs: Mature cells that wrap selected axons with compact myelin
Myelination requires coordinated signaling between SCs and axons:
- Neuregulin-1 type III: Axonal signal that promotes SC differentiation and survival
- Notch signaling: Inhibits myelination of smaller axons
- cAMP elevation: Triggers myelin gene expression
- PI3K/Akt/mTOR pathway: Drives myelin synthesis and growth
The resulting myelin sheath consists of ~50-100 lipid-rich membrane layers, with compact myelin (major dense line and intraperiod line) alternating with non-compact myelin (Schmidt-Lanterman incisures, paranodal loops).
Functions in Neurodegeneration
Support of Axonal Integrity
Myelinating SCs provide essential support to the axons they myelinate:
- Metabolic coupling: Supply lactate and pyruvate to axons via monocarboxylate transporters
- Neurotrophic support: Secrete NGF, BDNF, and GDNF
- Ion homeostasis: Buffer extracellular potassium at nodes of Ranvier
- Axonal transport: Maintain cytoskeletal organization for fast axonal transport
Demyelination and Axonal Loss
In peripheral neuropathies, demyelination precedes and triggers axonal degeneration:
- Loss of SC support leads to metabolic crisis in axons
- Demyelinated axons become hyperexcitable
- Inflammatory demyelination exposes axons to immune attack
Wallerian Degeneration
Following nerve injury, SCs undergo Wallerian degeneration:
- Dedifferentiate to repair SCs
- Clear myelin debris
- Form Bands of Büngner to guide axonal regeneration
- Remyelinate regenerating axons
Role in Peripheral Neuropathies
Charcot-Marie-Tooth Disease
CMT represents the most common inherited peripheral neuropathy, with many forms involving SC dysfunction:
- CMT1A (PMP22 duplication): Defective myelin formation by SCs
- CMT1X (GJB1 mutations): Gap junction dysfunction in SCs
- CMT1B (MPZ mutations): Defective myelin protein zero
Guillain-Barré Syndrome
GBS is an autoimmune demyelinating neuropathy where autoantibodies target:
- Peripheral myelin proteins (P0, PMP22)
- Gangliosides (GM1, GD1a)
- Compact myelin components
Diabetic Neuropathy
Metabolic dysfunction in diabetes affects SCs:
- Hyperglycemia-induced oxidative stress
- Advanced glycation end-products
- Impaired neuregulin signaling
- Reduced trophic support to axons
Therapeutic Implications
- cAMP elevators: Dibutyryl-cAMP, rolipram enhance SC differentiation
- Neuregulin-1: Growth factor therapy promotes myelination
- Vitamin D3: Promotes SC maturation
Neuroprotection
- Neurotrophic factors: NGF, BDNF, GDNF support axonal survival
- Antioxidants: Combat oxidative stress in SCs
- Anti-inflammatory: Reduce immune-mediated damage
See Also
- [Cell-Types/Myelinating-Schwann-Cells — This page](/cell-types)
Background
The study of Myelinating Schwann Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
- [Nave KA, Werner HB. Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol. 2014;30:503-533.](/mechanisms)
- [Salzer JL. Schwann cell myelination. Cold Spring Harb Perspect Biol. 2015;7(8):a020529.](/technologies/spect)